A carregar...
Emerging pharmacologic therapies for primary sclerosing cholangitis
PURPOSE OF REVIEW: The only currently approved treatment for primary sclerosing cholangitis (PSC) is liver transplantation, with a median time to transplant of 12–18 years after diagnosis. There are a number of emerging drugs that have the potential to meet this critically unmet need that will be su...
Na minha lista:
| Publicado no: | Curr Opin Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5646688/ https://ncbi.nlm.nih.gov/pubmed/28257308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOG.0000000000000352 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|